دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Coming Full Circle: Prioritizing Early Glycemic Control to Reduce Microvascular and Macrovascular Complications in People With Type 2 Diabetes
Kamlesh Khunti; Vanita R. Aroda
doi : 10.2337/dci21-0064
Perturbation of Glucose Homeostasis During Acute Illness: Stress Hyperglycemia and Relative Hypoglycemia
Gian Paolo Fadini
doi : 10.2337/dci21-0069
Assessing the Causal Role of Sleep Traits on Glycated Hemoglobin: A Mendelian Randomization Study
Junxi Liu; Rebecca C. Richmond; Jack Bowden; Ciarrah Barry; Hassan S. Dashti; Iyas Daghlas; Jacqueline M. Lane; Samuel E. Jones; Andrew R. Wood; Timothy M. Frayling; Alison K. Wright; Matthew J. Carr; Simon G. Anderson; Richard A. Emsley; David W. Ray; Michael N. Weedon; Richa Saxena; Deborah A. Lawlor; Martin K. Rutter
doi : 10.2337/dc21-0089
The Incidence of Diabetes Among 2,777,768 Veterans With and Without Recent SARS-CoV-2 Infection
Pandora L. Wander; Elliott Lowy; Lauren A. Beste; Luis Tulloch-Palomino; Anna Korpak; Alexander C. Peterson; Steven E. Kahn; Edward J. Boyko
doi : 10.2337/dc21-1686
Trends in the Incidence of Hospitalization for Major Diabetes-Related Complications in People With Type 1 and Type 2 Diabetes in Australia, 2010–2019
Jedidiah I. Morton; Peter A. Lazzarini; Jonathan E. Shaw; Dianna J. Magliano
doi : 10.2337/dc21-2268
Neighborhood Socioeconomic Environment and Risk of Type 2 Diabetes: Associations and Mediation Through Food Environment Pathways in Three Independent Study Samples
Lorna E. Thorpe; Samrachana Adhikari; Priscilla Lopez; Rania Kanchi; Leslie A. McClure; Annemarie G. Hirsch; Carrie R. Howell; Aowen Zhu; Farrokh Alemi; Pasquale Rummo; Elizabeth L. Ogburn; Yasemin Algur; Cara M. Nordberg; Melissa N. Poulsen; Leann Long; April P. Carson; Shanika A. DeSilva; Melissa Meeker; Brian S. Schwartz; David C. Lee; Karen R. Siegel; Giuseppina Imperatore; Brian Elbel
doi : 10.2337/dc21-1693
Gut Microbiome Composition Is Predictive of Incident Type 2 Diabetes in a Population Cohort of 5,572 Finnish Adults
Matti O. Ruuskanen; Pande P. Erawijantari; Aki S. Havulinna; Yang Liu; Guillaume Méric; Jaakko Tuomilehto; Michael Inouye; Pekka Jousilahti; Veikko Salomaa; Mohit Jain; Rob Knight; Leo Lahti; Teemu J. Niiranen
doi : 10.2337/dc21-2358
Glucagon-Like Peptide 1 Receptor Agonists and Sodium–Glucose Cotransporter 2 Inhibitors and Risk of Nonalcoholic Fatty Liver Disease Among Patients With Type 2 Diabetes
Richeek Pradhan; Hui Yin; Oriana Yu; Laurent Azoulay
doi : 10.2337/dc21-1953
Osteocalcin and Risks of Incident Diabetes and Diabetic Kidney Disease: A 4.6-Year Prospective Cohort Study
Xiaoqi Ye; Rong Yu; Fusong Jiang; Xuhong Hou; Li Wei; Yuqian Bao; Weiping Jia
doi : 10.2337/dc21-2113
Costs of Public Health Screening of Children for Presymptomatic Type 1 Diabetes in Bavaria, Germany
Florian M. Karl; Christiane Winkler; Anette-Gabriele Ziegler; Michael Laxy; Peter Achenbach
doi : 10.2337/dc21-1648
Plasma Industrial and Ruminant Trans Fatty Acids and Incident Type 2 Diabetes in the EPIC-Potsdam Cohort
Marcela Prada; Clemens Wittenbecher; Fabian Eichelmann; Andreas Wernitz; Olga Kuxhaus; Janine Kröger; Cornelia Weikert; Matthias B. Schulze
doi : 10.2337/dc21-1897
Trans Fatty Acid Biomarkers and Incident Type 2 Diabetes: Pooled Analysis of 12 Prospective Cohort Studies in the Fatty Acids and Outcomes Research Consortium (FORCE)
Heidi T.M. Lai; Fumiaki Imamura; Andres V. Ardisson Korat; Rachel A. Murphy; Nathan Tintle; Julie K. Bassett; Jiaying Chen; Janine Kröger; Kuo-Liong Chien; Mackenzie Senn; Alexis C. Wood; Nita G. Forouhi; Matthias B. Schulze; William S. Harris; Ramachandran S. Vasan; Frank Hu; Graham G. Giles; Allison Hodge; Luc Djousse; Ingeborg A. Brouwer; Frank Qian; Qi Sun; Jason H.Y. Wu; Matti Marklund; Rozenn N. Lemaitre; David S. Siscovick; Amanda M. Fretts; Aladdin H. Shadyab; JoAnn E. Manson; Barbara V. Howard; Jennifer G. Robinson; Robert B. Wallace; Nick J. Wareham; Yii-Der Ida Chen; Jerome I. Rotter; Michael Y. Tsai; Renata Micha; Dariush Mozaffarian; the Fatty Acids and Outcomes Research Consortium (FORCE)
doi : 10.2337/dc21-1756
Persistence of Risk for Type 2 Diabetes After Gestational Diabetes Mellitus
Mary V. Diaz-Santana; Katie M. O’Brien; Yong-Moon Mark Park; Dale P. Sandler; Clarice R. Weinberg
doi : 10.2337/dc21-1430
Heterogeneity of Type 1 Diabetes at Diagnosis Supports Existence of Age-Related Endotypes
Anna Parviainen; Taina Härkönen; Jorma Ilonen; Anna But; Mikael Knip; the Finnish Pediatric Diabetes Register
doi : 10.2337/dc21-1251
Increased Risk of Incident Diabetes Among Individuals With Latent Tuberculosis Infection
Matthew J. Magee; Anjali Khakharia; Neel R. Gandhi; Cheryl L. Day; Hardy Kornfeld; Mary K. Rhee; Lawrence S. Phillips
doi : 10.2337/dc21-1687
Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study
Peter Rossing; Ellen Burgess; Rajiv Agarwal; Stefan D. Anker; Gerasimos Filippatos; Bertram Pitt; Luis M. Ruilope; Pieter Gillard; Richard J. MacIsaac; Julio Wainstein; Amer Joseph; Meike Brinker; Lothar Roessig; Charlie Scott; George L. Bakris; on behalf of the FIDELIO-DKD Investigators
doi : 10.2337/dc21-1944
Efficacy and Safety of K-877 (Pemafibrate), a Selective PPARα Modulator, in European Patients on Statin Therapy
Henry N. Ginsberg; Neil J. Hounslow; Yusuke Senko; Hideki Suganami; Pawel Bogdanski; Richard Ceska; Akos Kalina; Roman A. Libis; Tatiana V. Supryadkina; G. Kees Hovingh
doi : 10.2337/dc21-1288
Primary Prevention of Cardiovascular and Heart Failure Events With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Their Combination in Type 2 Diabetes
Alison K. Wright; Matthew J. Carr; Evangelos Kontopantelis; Lalantha Leelarathna; Hood Thabit; Richard Emsley; Iain Buchan; Mamas A. Mamas; Tjeerd P. van Staa; Naveed Sattar; Darren M. Ashcroft; Martin K. Rutter
doi : 10.2337/dc21-1113
Comparative Safety of Sodium–Glucose Cotransporter 2 Inhibitors Versus Dipeptidyl Peptidase 4 Inhibitors and Sulfonylureas on the Risk of Diabetic Ketoacidosis
Ghadeer K. Dawwas; James H. Flory; Sean Hennessy; Charles E. Leonard; James D. Lewis
doi : 10.2337/dc21-2177
Impaired Hepatic Mitochondrial Capacity in Nonalcoholic Steatohepatitis Associated With Type 2 Diabetes
Sofiya Gancheva; Sabine Kahl; Dominik Pesta; Lucia Mastrototaro; Bedair Dewidar; Klaus Strassburger; Ehsan Sabah; Irene Esposito; Jürgen Weiß; Theresia Sarabhai; Martin Wolkersdorfer; Thomas Fleming; Peter Nawroth; Marcel Zimmermann; Andreas S. Reichert; Matthias Schlensak; Michael Roden
doi : 10.2337/dc21-1758
Association of Baseline HbA1c With Cardiovascular and Renal Outcomes: Analyses From DECLARE-TIMI 58
Avivit Cahn; Stephen D. Wiviott; Ofri Mosenzon; Erica L. Goodrich; Sabina A. Murphy; Ilan Yanuv; Aliza Rozenberg; Deepak L. Bhatt; Lawrence A. Leiter; Darren K. McGuire; John P.H. Wilding; Ingrid A.M. Gause-Nilsson; Anna Maria Langkilde; Marc S. Sabatine; Itamar Raz
doi : 10.2337/dc21-1744
The Impact of the Stress Hyperglycemia Ratio on Short-term and Long-term Poor Prognosis in Patients With Acute Coronary Syndrome: Insight From a Large Cohort Study in Asia
Jie Yang; Yitian Zheng; Chen Li; Jun Gao; Xiangbin Meng; Kuo Zhang; Wenyao Wang; Chunli Shao; Yi-Da Tang
doi : 10.2337/dc21-1526
Arterial Stiffness, Genetic Risk, and Type 2 Diabetes: A Prospective Cohort Study
Mengying Wang; Jie Huang; Tao Wu; Lu Qi
doi : 10.2337/dc21-1921
Phenomapping-Derived Tool to Individualize the Effect of Canagliflozin on Cardiovascular Risk in Type 2 Diabetes
Evangelos K. Oikonomou; Marc A. Suchard; Darren K. McGuire; Rohan Khera
doi : 10.2337/dc21-1765
Lifetime Cardiovascular Disease Risk by Coronary Artery Calcium Score in Individuals With and Without Diabetes: An Analysis From the Multi-Ethnic Study of Atherosclerosis
Bart S. Ferket; M.G. Myriam Hunink; Umesh Masharani; Wendy Max; Joseph Yeboah; Gregory L. Burke; Kirsten E. Fleischmann
doi : 10.2337/dc21-1607
COVID-19–Related Multisystem Inflammatory Syndrome in Children Presenting With New-Onset Type 1 Diabetes in Severe Ketoacidosis: A Case Series
Hanan H. Aly; Eman M. Fouda; Alyaa A. Kotby; Sondos M. Magdy; Ahmed R. Rezk; Marwa W.A. Nasef
doi : 10.2337/dc21-1094
Home Use of Mini-Dose Glucagon As a Novel Treatment for Hypoglycemia Following Repeated, Prolonged Fasts in Type 1 Diabetes During Ramadan
Metab Algeffari; Sufyan Hussain; Turki Almogbel; Mansour Alsharidah; Habibah Alghadouni; Farid Mahmood
doi : 10.2337/dc21-1655
The Incidence of Adult-Onset Type 1 Diabetes: A Systematic Review From 32 Countries and Regions
Jessica L. Harding; Pandora L. Wander; Xinge Zhang; Xia Li; Suvi Karuranga; Hongzhi Chen; Hong Sun; Yuting Xie; Richard A. Oram; Dianna J. Magliano; Zhiguang Zhou; Alicia J. Jenkins; Ronald C.W. Ma
doi : 10.2337/dc21-1752
Comparable Cardiorenal Benefits of SGLT2 Inhibitors and GLP-1RAs in Asian and White Populations: An Updated Meta-analysis of Results From Randomized Outcome Trials
Huilin Tang; Stephen E. Kimmel; Steven M. Smith; Kenneth Cusi; Weilong Shi; Matthew Gurka; Almut G. Winterstein; Jingchuan Guo
doi : 10.2337/dc21-1722
Metabolomics and Type 2 Diabetes Risk: An Updated Systematic Review and Meta-analysis of Prospective Cohort Studies
Jakub Morze; Clemens Wittenbecher; Lukas Schwingshackl; Anna Danielewicz; Andrzej Rynkiewicz; Frank B. Hu; Marta Guasch-Ferré
doi : 10.2337/dc21-1705
Erratum. Complications of Antenatal Corticosteroids in Infants Born by Early Term Scheduled Cesarean Section. Diabetes Care 2020;43:906–908
Katharine Gupta; Rohit Rajagopal; Felicia King; David Simmons
doi : 10.2337/dc22-er04
The COVID-19 Pandemic and Changes in Health Care Utilization Among Patients With Type 2 Diabetes
Julius L. Chen; Gina R. Krupp; Justin Y. Lo
doi : 10.2337/dc21-2248
Type 1 Diabetes in Children With Genetic Risk May Be Predicted Very Early With a Blood miRNA
Tomi Suomi; Ubaid Ullah Kalim; Omid Rasool; Asta Laiho; Henna Kallionpää; Mari Vähä-Mäkilä; Mirja Nurmio; Juha Mykkänen; Taina Härkönen; Heikki Hyöty; Jorma Ilonen; Riitta Veijola; Jorma Toppari; Mikael Knip; Laura L. Elo; Riitta Lahesmaa
doi : 10.2337/dc21-2120
Comment on Dawed et al. Genome-Wide Meta-Analysis Identifies Genetic Variants Associated With Glycemic Response to Sulfonylureas. Diabetes Care 2021;44:2673–2682
Ke Wang; Mai Shi; Aimin Yang; Brian Tomlinson; Juliana C.N. Chan; Elaine Chow
doi : 10.2337/dc21-2428
Response to Comment on Dawed et al. Genome-Wide Meta-analysis Identifies Genetic Variants Associated With Glycemic Response to Sulfonylureas. Diabetes Care 2021;44:2673–2682
Adem Y. Dawed; Sook Wah Yee; Kaixin Zhou; Nienke van Leeuwen; Yanfei Zhang; Moneeza K. Siddiqui; Amy Etheridge; Federico Innocenti; Fei Xu; Josephine H. Li; Joline W. Beulens; Amber A. van der Heijden; Roderick C. Slieker; Yu-Chuan Chang; Josep M. Mercader; Varinderpal Kaur; John S. Witte; Ming Ta Michael Lee; Yoichiro Kamatani; Yukihide Momozawa; Michiaki Kubo; Colin N.A. Palmer; Jose C. Florez; Monique M. Hedderson; Leen M. 't Hart; Kathleen M. Giacomini; Ewan R. Pearson; for MetGen Plus, for the DIRECT Consortium
doi : 10.2337/dci21-0066
Comment on Aleppo et al. The Effect of Discontinuing Continuous Monitoring in Adults With Type 2 Diabetes Treated With Basal Insulin. Diabetes Care 2021;44:2729–2737
Mayer B. Davidson
doi : 10.2337/dc21-2705
Response to Comment on Aleppo et al. The Effect of Discontinuing Continuous Glucose Monitoring in Adults With Type 2 Diabetes Treated With Basal Insulin. Diabetes Care 2021;44:2729–2737
Ryan Bailey; Peter Calhoun; Roy W. Beck; Richard M. Bergenstal; Grazia Aleppo
doi : 10.2337/dci22-0006
